Cover Image

Correction to “Clinical evaluation of primary human papillomavirus ( HPV ) testing with extended HPV genotyping triage for cervical cancer screening: A pooled analysis of individual patient data from nine population‐based cervical cancer screening studies from China”

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Cancer Medicine
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Clinical evaluation of primary human papillomavirus (HPV) testing with extended HPV genotyping triage for cervical cancer screening: A pooled analysis of individual patient data from nine population‐based cervical cancer screening studies from China
by: Changchang Dun, et al.
Published: (2024)

Cost‐effectiveness analysis of human papillomavirus ( HPV ) genotyping strategies for management of HPV ‐positive women in cervical cancer screening
by: Kelsi R. Kroon, et al.
Published: (2026)

Pooled performance of urinary human papillomavirus (HPV) testing for the presence of cervical HPV
by: Zichen Ye, et al.
Published: (2025)

Retrospective analysis of HPV infection: Cotesting and HPV genotyping in cervical cancer screening within a large academic health care system
by: Frances Xiuyan Feng, et al.
Published: (2024)

Extended HPV genotyping and dual stain for the triage of primary HPV screen‐positive cases: Practical guidance for the cytopathology laboratory
by: Robert A. Goulart, et al.
Published: (2025)

Health care policy trial of primary human papillomavirus–based cervical screening in Denmark: Comparison of three triage algorithms
by: Jeppe Bennekou Schroll, et al.
Published: (2026)

Perspective of obstetric care‐providers on being involved in cervical cancer screening during antenatal care in the Netherlands
by: Nick M. A. van der Hoeven, et al.
Published: (2024)

Field experience with the 8‐HPV‐type oncoprotein test for cervical cancer screening among HPV‐positive women living with and without HIV in LMICs
by: Laura Downham, et al.
Published: (2024)

Evaluating human papillomavirus (HPV) self‐sampling among Latinas in the United States: A systematic review
by: Marisol S. Cora‐Cruz, et al.
Published: (2024)

RNA extended interventional nucleic acid longitudinal study: Clinical performance of Aptima messenger RNA HPV testing in cervical cancer screening with a 9‐year follow‐up
by: Rosario Granados, et al.
Published: (2024)

Clinically validated HPV assays offer comparable long‐term safety in primary cervical cancer screening: A 9‐year follow‐up of a population‐based screening cohort
by: Anja Oštrbenk Valenčak, et al.
Published: (2024)

The impact of loss to follow‐up in the Dutch organised HPV‐based cervical cancer screening programme
by: E. M. G. Olthof, et al.
Published: (2024)

Controlled trial of cervical cancer screening frequency among human‐papillomavirus‐vaccinated women
by: Mònica Ortega Llobet, et al.
Published: (2025)

Correction to “Self‐collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline”
Published: (2026)

Reinforcement learning for individualized lung cancer screening schedules: A nested case–control study
by: Zixing Wang, et al.
Published: (2024)

The efficacy of first and second immunotherapy exposure in patients with recurrent or metastatic cervical cancer
by: Mingxiu Ju, et al.
Published: (2024)

Self‐collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline
by: Rebecca B. Perkins, et al.
Published: (2025)

Acceptability and validity of HPV self‐sampling for cervical cancer screening among women living in different ecological settings in India
by: Gauravi A. Mishra, et al.
Published: (2024)

p16/ki‐67 dual stain triage of individuals positive for HPV to detect cervical precancerous lesions
by: Diane M. Harper, et al.
Published: (2025)

Single visit screen‐triage‐treat strategy using GeneXpert ‐based HPV testing of self‐collected cervicovaginal samples and thermal ablation treatment for cervical cancer prevention among women in Lilongwe, Malawi
by: Lameck Chinula, et al.
Published: (2025)

A highly sensitive screening system to evaluate the reversibility of neuroendocrine prostate cancer to prostate adenocarcinoma
by: Tomohiro Fukui, et al.
Published: (2025)

Should the age range of the Dutch hrHPV‐based cervical cancer screening program be broadened? A modelling study using cohort effects
by: Sylvia Kaljouw, et al.
Published: (2025)

Cost‐effectiveness of risk‐stratified screening for cervical cancer in cohorts vaccinated against human papillomavirus with moderate vaccination coverage
by: Tiago M. de Carvalho, et al.
Published: (2026)

A novel nomogram based on inflammation biomarkers for predicting radiation cystitis in patients with local advanced cervical cancer
by: Jie Lin, et al.
Published: (2024)

“Other” high‐risk HPV: Challenges in anal cancer screening
by: Margaret L. Compton
Published: (2025)

Risk stratification and anal cancer screening in immunocompetent women with genital HPV : Value of multicentric HSIL and performance of HPV ‐based screening
by: Isabel Matas, et al.
Published: (2026)

Elimination of cervical cancer by refined vaccination and screening
by: Matti Lehtinen, et al.
Published: (2024)

Epidemiological approaches to evaluate clinical unmasking of HPV ‐associated cervical lesions in the HPV vaccination era
by: Joseph E. Tota, et al.
Published: (2025)

Australian guidelines for anal cancer screening using anal human papillomavirus testing with cytology triage in people living with HIV
by: I. M. Poynten, et al.
Published: (2025)

Artificial intelligence in lung cancer screening: Detection, classification, prediction, and prognosis
by: Wu Quanyang, et al.
Published: (2024)

Preference for breast cancer screening in Chinese women: Discrete choice experiment
by: Shuning Wu, et al.
Published: (2025)

Report provides review of major modifiable cancer risk factors, HPV vaccination, and cancer screenings
by: Mary Beth Nierengarten
Published: (2025)

HRSA recommends offering self‐collection for cervical cancer screening
by: Leah Lawrence
Published: (2026)

Evaluation of targeted next‐generation sequencing for detection of HPV genotypes and sublineages in cervical liquid‐based cytology SurePath samples from the Danish screening program
by: Karoline Andersen, et al.
Published: (2025)

Habitat Radiomics Predict HPV Status in Oropharyngeal Cancer
by: Oya Altinok, et al.
Published: (2025)

Clinicopathological features, prognostic factor analysis, and survival nomogram of patients with double primary cancers involving lung cancer
by: Yuxuan Hao, et al.
Published: (2024)

Opportunistic lung cancer screening with low‐dose computed tomography in National Cancer Center of China: The first 14 years' experience
by: Wei Tang, et al.
Published: (2024)

Correlation of different HPV genotype viral loads and cervical lesions: A retrospective analysis of 1585 cases
by: Yilu Zhou, et al.
Published: (2024)

Participant factors associated with psychosocial impacts of lung cancer screening: A systematic review
by: Kathleen McFadden, et al.
Published: (2024)

Under which realistic circumstances is hrHPV self‐sampling increasing cervical screening effectiveness in a partly vaccinated population? A modelling study
by: Sylvia Kaljouw, et al.
Published: (2025)